Tempus AI成功获得来自美国高级卫生研究计划局（Arpa-H）的“倡导者”项目资助，金额最高可达950万美元。这笔资金将专门用于推动其在心脏病学领域部署首款完全自主运行的人工智能系统。
这一里程碑式的进展意味着，Tempus AI正站在将自主AI技术引入心血管诊疗的最前沿。借助这笔关键资金，该公司计划加速其创新解决方案的临床落地，有望彻底革新心脏病的检测、诊断与管理方式。
获得Arpa-H的认可，不仅凸显了Tempus AI在医疗AI赛道上的技术领导力，也为未来更广泛、更深入的自动化临床决策支持系统铺平了道路。这笔专项拨款将为其在心脏病学这一关键领域的深度应用提供强劲动力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.